Mirum Pharmaceuticals, Inc.
https://mirumpharma.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Mirum Pharmaceuticals, Inc.
First-In-Class Drugs Made Up More Than Half Of US FDA’s Novel Approvals Last Year
CDER hit a high mark with 27 first-in-class approvals in the 50 novel agents cleared in 2021.
First Chinese Rare Disease Biotech IPO To Spark Interest In Less Travelled Path?
CanBridge public listing is expected to generate much needed funding and spotlights a largely untapped but challenging segment.
Rare EU Fast-Track Nod For Sanofi Genzyme's Olipudase Alfa
Only three planned marketing authorization applications are known to have been granted accelerated assessment status by the European Medicines Agency between July and October this year.
First-Of Kind BMS Drugs Among Myriad New Filings In EU
Marketing applications for 10 new drugs have been added to the latest list of products under review by the European Medicines Agency.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Specialty Pharmaceuticals